Pharmacy Spotlight: Don Summerfield of Medly Pharmacy

What are consumers looking for from homeopathy today? As manufacturers, how can we best serve them? An excellent way to get a pulse on our consumers is to look to those who engage closely with them every day—homeopathic pharmacies and other natural retailers. In the second installment of our Pharmacy readm more…

Read More

Your NDC Numbers are About to Change

By Eric Foxman, AAHP Secretary FDA has published a proposal that will change the required National Drug Code (NDC) format from 10 to 12 digits. Once finalized, all NDC holders would be required to convert to the new format. Because of the significant burden this may entail, FDA is proposing readm more…

Read More

This Year’s AAHP Summit On Hold Until 2023

Now in its fourth year, the AAHP Summit series has gathered the industry for feedback while the HPCUS works through five compliance gaps that challenge manufacturers and FDA inspectors alike. The volunteers for this multiyear project are hard at work on the next phase, which upon completion will be the readm more…

Read More

FDA Seeks Accelerated Drug Approval, DSHEA, Cosmetics Legislative Reforms

By Pete Evich, AAHP Government Relations As part of the President’s FY 2023 Budget proposal, FDA has called upon Congress to take up legislation that would give the agency additional authorities over accelerated approval of drugs and the ability to impose new requirements for dietary supplement makers and cosmetics facilities, readm more…

Read More

The Regulation of Homeopathic Medicines in 2022

By Mark Land, AAHP President   The content in our June 2022 newsletter on regulation turned out quite different than I imagined when we discussed it at an editorial planning committee meeting several months ago. I envisioned the regulatory issue to include several articles from authors around the world, each readm more…

Read More

Regulation of Homeopathic Medicines in Canada

Submitted by David Skinner, Canadian Homeopathic Pharmaceutical Association   Homeopathic medicines (HMs) are regulated in Canada by Health Canada, the federal government department responsible for ensuring the safety, efficacy, and compositional integrity of health care products and medical devices distributed and sold in Canada. Health Canada has formally recognized HMs readm more…

Read More

Recent HPCUS Meetings and Updates

By Eric Foxman, Pharm. (Ret.), AAHP Secretary The Homeopathic Pharmacopoeia Convention of the United States held its annual meeting in the latter half of April. This included both the Board and general membership meetings. Many of the working committees also held meetings within the same time frame. For the third readm more…

Read More